Trinity Biotech TRIB
NASDAQ TRIB
$8.93 -0.08 (-0.89%)
As of: Sep 9, 2026 · 12:35 PM EDT

Trinity Biotech (TRIB) Amortization - Intangibles (2014 - 2024)

Trinity Biotech's (TRIB) quarterly Amortization - Intangibles came in at $338.0 in Q3 2024, up 503.57% year-over-year from $56.0 in Q4 2023, and up 55.05% quarter-over-quarter from $218.0 in Q2 2024.

Analysis

Trinity Biotech (TRIB) Amortization - Intangibles (2014 - 2024) Analysis & Trends

Trinity Biotech has disclosed Amortization - Intangibles across 5 years of filings, most recently posting $338.0 for Q3 2024.

  • In Q3 2024, Amortization - Intangibles rose 503.57% year-over-year to $338.0; the TTM figure through Sep 2024 stood at $1139.0 (down 99.96% YoY), while the FY2016 annual figure was $3.0 million, up 12.06% from the prior year.
  • Amortization - Intangibles came in at $338.0 for Q3 2024 at Trinity Biotech, up from $218.0 in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $527.0 in Q1 2024 to a low of $56.0 in Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 GE HealthCare Technologies 29.83 Bn 27.72 Bn 2.18 Bn
2 Lantheus Holdings 6.58 Bn 5.99 Bn 241.86 Mn
3 Heartflow 4.12 Bn 3.74 Bn 53.19 Mn
4 Neogen 2.59 Bn 2.41 Bn 107.80 Mn
5 Butterfly Network 1.99 Bn 1.86 Bn 23.29 Mn
6 Ceribell 924.18 Mn 794.92 Mn 25.94 Mn
7 QuidelOrtho 887.56 Mn 764.16 Mn -
8 Varex Imaging 779.06 Mn 679.86 Mn 76.70 Mn
9 Prenetics Global 338.23 Mn 279.18 Mn 30.20 Mn
10 Trinity Biotech 5.81 Mn 5.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 338.00
Jun 30, 2024 218.00
Mar 31, 2024 527.00
Sep 30, 2023 56.00
Jun 30, 2023 179.00
Mar 31, 2023 251.00
Dec 31, 2016 2.97 Mn
Dec 31, 2015 2.65 Mn
Dec 31, 2014 2.38 Mn